Latest News in the pharma Industry
Top Stories
Jardiance is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial
18 Sep 2015
Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company's Jardiance (empagliflozin) significantly reduced the risk of the combined endpoint of cardiovascular (CV) death, non-fatal heart attack or non-fatal stroke by 14% when added to standard of...
Read more
CPhI expert warns without urgent regulatory change improving quality is a fool’s game
18 Sep 2015
Girish Malhotra believes the pharmaceutical industry should be allowed to commercialise process improvements without regulatory re-approval.
Read more
Piramal encourages pharma to embrace green chemistry ahead of CPhI
18 Sep 2015
Processes improvements for original patented products need to be considered, as do improvements beyond even DMF and ANDA submission.
Read more
The new age of regenerative medicine: why stem cell therapy?
18 Sep 2015
Frost & Sullivan webinar reveals stem cell therapy pipeline and treatments innovating regenerative medicine.
Read more
Victoza (liraglutide) provides significantly greater HbA1c reduction than lixisenatide in new clinical trial
17 Sep 2015
Findings from a head-to-head trial comparing Victoza (liraglutide) and lixisenatide, both in combination with metformin, demonstrated a significantly greater reduction in HbA1c of -1.83% for liraglutide vs -1.21% for lixisenatide in adults with type 2 ...
Read more
CEVEC and Généthon sign a collaboration agreement to develop lentiviral vector packaging cell lines based on CEVEC’s proprietary CAP GT technology
17 Sep 2015
Agreement enables fully scalable, industrial lentivirus vector production
Read more
Impax receives FDA approval for generic version of Mestinon Timespan Tablets, 180 mg
17 Sep 2015
First generic product approved from Hayward manufacturing facility following recent resolution of Warning Letter
Read more
Merck's omarigliptin achieved similar A1C reductions to Januvia in patients with type 2 diabetes inadequately controlled on Metformin monotherapy
17 Sep 2015
Omarigliptin was found to be non-inferior to Merck’s once-daily DPP-4 inhibitor, Januvia (sitagliptin), at reducing patients’ A1C levels from baseline, with similar A1C reductions achieved in both groups.
Read more
Using proteomics to understand how genetic mutations rewire cancer cells
17 Sep 2015
Scientific publications highlight studies using data from Thermo Scientific Orbitrap mass spectrometry and next-generation sequencing to discover how cancer attacks the protein networks controlling human cells
Read more
Sandoz inaugurates BioInject — a new biopharmaceutical manufacturing facility in Schaftenau, Austria
17 Sep 2015
BioInject is a state-of-the-art facility that will be used to manufacture pre-filled syringes and devices for both Sandoz’s biosimilars and Novartis Pharma’s novel biologics.
Read more
Technical knowledge alone is not enough for pharmaceutical professionals
16 Sep 2015
Pharmaceutical professionals must develop wider commercial and business skills if they want to continue to secure the top jobs, according to NonStop Recruitment.
Read more
Amgen to acquire privately-held Dezima Pharma
16 Sep 2015
Dezima's lead molecule is TA-8995, an oral, once-daily cholesteryl ester transfer protein (CETP) inhibitor.
Read more